Behavioral
Sgoh Acquisition INC
Sgoh Acquisition INC was paid $10.82M by Medicaid between Jan 2018 and Dec 2024, across 139 billing codes. Its largest line is X4003, — 31% of everything it billed.
33Billing provider infoSGOH ACQUISITION INC
GRAVETTE, AR 72736
GRAVETTE, AR 72736
33aNPI1568643005assigned 11/26/2007
33bProvider typePsychologist
28Total paid$10.82M
24GClaims249,592
24DCodes billed139
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychologist providers in Arkansas
Rank by total paid#1 of 10
Median peer was paid$69K
This provider vs. median157×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TAYLOR, PAUL controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,962 | $3.22M | |
| 2019 | 36,851 | $2.54M | |
| 2020 | 35,357 | $1.29M | |
| 2021 | 36,551 | $933K | |
| 2022 | 36,946 | $1.09M | |
| 2023 | 37,736 | $1.25M | |
| 2024incomplete | 22,189 | $502K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| X4003 | 31% | 25,572 | 22,358 | $3.32M | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 31,158 | 22,907 | $1.91M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 13% | 16,058 | 14,048 | $1.37M |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 8.7% | 49,838 | 38,948 | $937K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 3.8% | 1,910 | 1,600 | $416K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.3% | 3,905 | 2,853 | $246K |
| D9999 | Unspecified adjunctive procedure, by report | 2.0% | 212 | 212 | $212K |
| X4006 | 1.9% | 207 | 181 | $210K | |
| Y7506 | 1.8% | 2,027 | 1,920 | $191K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 3,715 | 3,179 | $179K |
| 80053 | Comprehensive metabolic panel | 1.5% | 15,343 | 14,222 | $161K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 1,345 | 1,311 | $158K |
127 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 15,904 | $113K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.0% | 9,064 | $111K |
| 80061 | Lipid panel | <1% | 7,981 | $98K |
| 94060 | <1% | 567 | $72K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,866 | $71K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,698 | $64K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 651 | $63K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,562 | $54K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 790 | $51K |
| 99283 | Emergency room visit (moderate) | <1% | 632 | $50K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,060 | $49K |
| 80050 | General health panel | <1% | 883 | $42K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,268 | $41K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 571 | $41K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,043 | $40K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 984 | $40K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 305 | $37K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 510 | $36K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 540 | $34K |
| 94726 | <1% | 335 | $33K | |
| 94729 | <1% | 318 | $31K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 192 | $30K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 507 | $29K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,277 | $26K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 189 | $21K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 182 | $16K |
| 82607 | <1% | 1,198 | $14K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 88 | $13K |
| 94664 | <1% | 291 | $13K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 141 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 367 | $12K |
| 90837 | Psychotherapy session, about an hour | <1% | 326 | $11K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 138 | $10K |
| 80306 | <1% | 351 | $10K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 156 | $9K |
| 87634 | <1% | 97 | $8K | |
| 81001 | <1% | 1,233 | $6K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,551 | $6K |
| 81003 | <1% | 1,914 | $6K | |
| 96111 | <1% | 39 | $5K | |
| 90686 | <1% | 648 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 390 | $5K |
| 87430 | <1% | 387 | $5K | |
| 83655 | <1% | 68 | $5K | |
| 73630 | <1% | 242 | $4K | |
| 80348 | <1% | 317 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 579 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 21 | $4K |
| 87400 | <1% | 340 | $4K | |
| 72100 | <1% | 258 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 86 | $3K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 120 | $3K |
| 80362 | <1% | 240 | $3K | |
| 82043 | <1% | 409 | $3K | |
| 87807 | <1% | 14 | $2K | |
| 81025 | <1% | 230 | $2K | |
| 85027 | <1% | 187 | $2K | |
| 92552 | <1% | 13 | $2K | |
| 84439 | <1% | 270 | $2K | |
| 82746 | <1% | 168 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 297 | $2K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 194 | $2K |
| 99490 | Ccm add 20min | <1% | 72 | $1K |
| 82570 | <1% | 347 | $1K | |
| 85007 | <1% | 95 | $995.79 | |
| 83735 | <1% | 260 | $896.82 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 61 | $838.31 |
| 99221 | <1% | 13 | $786.73 | |
| G0008 | Administration of influenza virus vaccine | <1% | 135 | $653.00 |
| 99326 | <1% | 15 | $641.69 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 52 | $567.83 |
| 99337 | <1% | 33 | $408.43 | |
| 87806 | <1% | 17 | $386.62 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 12 | $357.09 |
| 99336 | <1% | 14 | $352.12 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 51 | $337.28 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 18 | $320.86 |
| 82728 | <1% | 28 | $311.38 | |
| 86803 | <1% | 35 | $284.58 | |
| 85651 | <1% | 76 | $283.50 | |
| 84436 | <1% | 13 | $254.68 | |
| 71020 | <1% | 17 | $204.00 | |
| 90649 | <1% | 23 | $200.76 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 15 | $199.37 |
| 99406 | <1% | 28 | $182.80 | |
| 1159F | <1% | 2,976 | $181.61 | |
| 80365 | <1% | 13 | $179.62 | |
| 1160F | <1% | 2,977 | $170.26 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 78 | $167.18 |
| 87420 | <1% | 13 | $153.41 | |
| 86140 | <1% | 44 | $153.17 | |
| 4004F | <1% | 2,819 | $147.56 | |
| 83540 | <1% | 28 | $146.18 | |
| 99441 | <1% | 81 | $136.96 | |
| 82550 | <1% | 19 | $131.37 | |
| 90633 | <1% | 15 | $124.28 | |
| 83550 | <1% | 15 | $117.10 | |
| 90734 | <1% | 12 | $114.72 | |
| 86706 | <1% | 16 | $112.71 | |
| 72040 | <1% | 12 | $91.68 | |
| 99285 | Emergency room visit (most serious) | <1% | 20 | $89.00 |
| 84484 | <1% | 19 | $84.30 | |
| 81002 | <1% | 13 | $31.97 | |
| 99606 | <1% | 22 | $3.25 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 2,920 | $0.04 |
| 3078F | 0% | 311 | $0.00 | |
| 3077F | 0% | 61 | $0.00 | |
| 99201 | 0% | 15 | $0.00 | |
| 80366 | 0% | 22 | $0.00 | |
| 80369 | 0% | 22 | $0.00 | |
| 80372 | 0% | 20 | $0.00 | |
| 99605 | 0% | 23 | $0.00 | |
| 80360 | 0% | 20 | $0.00 | |
| 80373 | 0% | 21 | $0.00 | |
| 80355 | 0% | 22 | $0.00 | |
| 80335 | 0% | 21 | $0.00 | |
| 80350 | 0% | 13 | $0.00 | |
| 3008F | 0% | 305 | $0.00 | |
| 80374 | 0% | 21 | $0.00 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 177 | $0.00 |
| 3079F | 0% | 68 | $0.00 | |
| 1125F | 0% | 96 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 38 | $0.00 |
| 80368 | 0% | 39 | $0.00 | |
| 3074F | 0% | 160 | $0.00 | |
| 3080F | 0% | 17 | $0.00 | |
| 80371 | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTAYLOR, PAUL (ADMINISTRATOR/CEO)
| Provider | Location | Paid |
|---|---|---|
| Sgoh Acquisition, INC. | Sparta, MO | $3.61M |
| Sgoh Acquisition INC | Rogersville, MO | $3.53M |
| Sgoh Acquisition INC | Springfield, MO | $2.85M |
| Sgoh Acquisition, INC. | Carthage, MO | $1.34M |
| Sgoh Acquisition, INC. | Anderson, MO | $681K |
| Sgoh Acquisition, INC. | Marshfield, MO | $620K |
| Sgoh Acquisition, INC. | Jay, OK | $601K |
| Sgoh Acquisition INC | Mount Vernon, MO | $476K |
| Sgoh Acquisition, INC. | Neosho, MO | $454K |
| Sgoh Acquisition, INC. | South West City, MO | $452K |
| Sgoh Acquisition, INC. | Pineville, MO | $367K |
| Sgoh Acquisition, INC. | Noel, MO | $297K |
| Sgoh Acquisition, INC. | Goodman, MO | $194K |
| Irish Taylor Dental LLC | Omaha, NE | $126K |
| Sgoh Acquisition INC | Rogers, AR | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.